v.231201
Showing details for project SYSMHC00038
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SampleID |
NumReplicates |
Organism |
TissueType |
CellType |
MHCAllele |
| SYSMHC00038_CD74siRNA_Tue39L243_Adjusted |
5 |
Human |
|
|
DRB1_1501,HLA-DQA10602-DQB10602 |
| SYSMHC00038_CD74siRNA_W_Adjusted |
5 |
Human |
|
|
HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-B47:01,HLA-C06:02,HLA-C07:02 |
| SYSMHC00038_CTRLsiRNA_Tue39L243_Adjusted |
5 |
Human |
|
|
DRB1_1501,HLA-DQA10602-DQB10602 |
| SYSMHC00038_CTRLsiRNA_W_Adjusted |
5 |
Human |
|
|
HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-B47:01,HLA-C06:02,HLA-C07:02 |
Detailed view of sample SYSMHC00038_CD74siRNA_Tue39L243_Adjusted
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue Type |
Cell Type |
Culture Conditions |
Disease State |
Comments |
MHCClass |
MHCAllele |
PubMed ID |
Peptide |
Isolation Method |
Antibody |
Mass Spectrometer |
LC System |
iRT Peptides |
Acquisition Mode |
Fragmentation Method |
Gradient |
Gradient Length |
Flow Rate |
Replicate Number |
| ID |
SampleID |
RawFileName |
Organism |
Process |
Tissue_Type |
Cell_Type |
Culture_Conditions |
Disease_State |
Comments |
MHCClass |
MHCAllele |
PubMed_ID |
Peptide |
Isolation_Method |
Antibody |
Mass_Spectrometer |
LC_System |
iRT_Peptides |
Acquisition_Mode |
Fragmentation_Method |
Gradient |
Gradient_Length |
Flow_Rate |
Replicate_Number |
| SYSMHC00038 |
SYSMHC00038_CD74siRNA_Tue39L243_Adjusted |
160122_DK_CoOp-PH_H1_CD74siRNA_Tue39L243_Adjusted_20_Rep4_msms18.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
|
class II |
DRB1_1501,HLA-DQA10602-DQB10602 |
29490700 |
native |
Immunoaffinity |
HB145 |
Orbitrap Fusion Lumos |
nanoflow high-performance liquid chromatography |
no |
DDA |
CID |
|
|
|
1 |
| SYSMHC00038 |
SYSMHC00038_CD74siRNA_Tue39L243_Adjusted |
160122_DK_CoOp-PH_H1_CD74siRNA_Tue39L243_Adjusted_20_Rep5_msms19.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
|
class II |
DRB1_1501,HLA-DQA10602-DQB10602 |
29490700 |
native |
Immunoaffinity |
HB145 |
Orbitrap Fusion Lumos |
nanoflow high-performance liquid chromatography |
no |
DDA |
CID |
|
|
|
2 |
| SYSMHC00038 |
SYSMHC00038_CD74siRNA_Tue39L243_Adjusted |
160122_DK_CoOp-PH_H1_CD74siRNA_Tue39L243_Adjusted_20_Rep3_msms17.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
|
class II |
DRB1_1501,HLA-DQA10602-DQB10602 |
29490700 |
native |
Immunoaffinity |
HB145 |
Orbitrap Fusion Lumos |
nanoflow high-performance liquid chromatography |
no |
DDA |
CID |
|
|
|
3 |
| SYSMHC00038 |
SYSMHC00038_CD74siRNA_Tue39L243_Adjusted |
160121_DK_CoOp-PH_H1_CD74siRNA_Tue39L243_20_DoseFinding_msms4.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
|
class II |
DRB1_1501,HLA-DQA10602-DQB10602 |
29490700 |
native |
Immunoaffinity |
HB145 |
Orbitrap Fusion Lumos |
nanoflow high-performance liquid chromatography |
no |
DDA |
CID |
|
|
|
4 |
| SYSMHC00038 |
SYSMHC00038_CD74siRNA_Tue39L243_Adjusted |
160122_DK_CoOp-PH_H1_CD74siRNA_Tue39L243_Adjusted_20_Rep2_msms16.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
|
class II |
DRB1_1501,HLA-DQA10602-DQB10602 |
29490700 |
native |
Immunoaffinity |
HB145 |
Orbitrap Fusion Lumos |
nanoflow high-performance liquid chromatography |
no |
DDA |
CID |
|
|
|
5 |